Cystic Fibrosis in Adults

  • Andrew Libertin
  • John S. Heintz
Part of the Contemporary Internal Medicine book series (COIM, volume 3)


A 21-year-old white female college student was referred for evaluation of an elevated sweat chloride test. She had been having chronic cough for the past two years, which had gradually increased in severity, and chronic sinus congestion for which she had been seeing an allergist. On further questioning, it was apparent that she had suffered from frequent cough and lingering colds over much of her life. Treatment prior to referral consisted of hyposensitization shots over the previous two years. At the initiation of her therapy, she had normal x-ray and pulmonary function tests. Treatment prior to referral had included the intermittent use of Rondec TR, Vancenase, a Proventil inhaler, and intermittent antibiotics. Just prior to referral her allergist obtained a sweat chloride test because of her poor response to therapy. This was elevated and she was referred for further evaluation and treatment.


Cystic Fibrosis Cystic Fibrosis Transmembrane Conductance Regulator Rectal Prolapse Pancreatic Insufficiency Nephrogenic Diabetes Insipidus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Buchwald M, Tsui LC, Riordan J: The search for the cystic fibrosis gene. Am J Physiol. 1989;257:L47–L52.PubMedGoogle Scholar
  2. 2.
    Boat T: Cystic fibrosis, in Murray J, Nadel J (eds): Textbook of Respiratory Medicine. Philadelphia, WB Saunders Co, 1988, pp 1126–1152.Google Scholar
  3. 3.
    Kerem BS, Buchanan JA, Durie P, et al: DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet. 1989;44:827–834.PubMedGoogle Scholar
  4. 4.
    Quinton PM: Chloride impermeability in cystic fibrosis. Nature. 1983;301:421–422.PubMedCrossRefGoogle Scholar
  5. 5.
    Quinton PM, Bigman J: Higher bioelectric potentials due to decreased chloride absorption in the sweat glands of patients with cystic fibrosis. N Engl J Med. 1983;308:1185–1189.PubMedCrossRefGoogle Scholar
  6. 6.
    Knowles MR, Stutts MJ, Spock A et al: Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science. 1983;221:1067–1070.PubMedCrossRefGoogle Scholar
  7. 7.
    Sato K, Sato F: Defective beta adrenergic response of cystic fibrosis sweat glands in vivo and in vitro. J Clin Invest. 1984;73:1763–1771.PubMedCrossRefGoogle Scholar
  8. 8.
    Frizzell RA, Rechkemmer G, Shoemaker RL: Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science. 1986;233:558–560.PubMedCrossRefGoogle Scholar
  9. 9.
    Li M, McCann JD, Liedtke CM: Cystic AMP-dependent protein kinase opens chloride channels in normal but not cystic fibrosis airway epithelium. Nature. 1988;331:358–360.PubMedCrossRefGoogle Scholar
  10. 10.
    Rommens JM, Iannuzzi MC, Kerem B, et al: Identification of the cystic fibrosis gene: Chromosome walking and jumping. Science. 1989;245:1059–1065.PubMedCrossRefGoogle Scholar
  11. 11.
    Riordan JR, Rommens JM, Kerem B, et al: Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 1989;245:1066–1073.PubMedCrossRefGoogle Scholar
  12. 12.
    Kerem B, Rommens JM, Buchanan JA, et al: Identification of the cystic fibrosis gene: genetic analysis. Science. 1989;245:1073–1080.PubMedCrossRefGoogle Scholar
  13. 13.
    Frates RC, Kaizu T, Last JA: Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients. Pediatr Res. 1983;17:30–34.PubMedCrossRefGoogle Scholar
  14. 14.
    Penketh ARL, Wise A, Mearns MB, et al: Cystic fibrosis in adolescents and adults. Thorax. 1987;42:526–532.PubMedCrossRefGoogle Scholar
  15. 15.
    Gaskin K, Gurwitz D, Durie P, et al: Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr. 1982;100:857–862.PubMedCrossRefGoogle Scholar
  16. 16.
    Wood RE, Boat TF, Doershuk CF: State of the art: Cystic fibrosis. Am Rev Respir Dis. 1976;113:833–878.PubMedGoogle Scholar
  17. 17.
    Stern RC, Boat TF, Doershuk CF: Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome. Lancet. 1982;1:1401–1403.PubMedCrossRefGoogle Scholar
  18. 18.
    Brasfield D, Hicks G: The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics. 1979;63:24–29.PubMedGoogle Scholar
  19. 19.
    Schwachman H, Kulczycki L: Long term study of one-hundred five patients with cystic fibrosis. J Dis Child. 1958;96:6–15.Google Scholar
  20. 20.
    Biller J, Grand R: Pancreatic disorders in childhood, in Sleisenger M, Fordtran J (cds): Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, ed 4. Philadelphia, WB Saunders Co, 1988, pp 1789–1813.Google Scholar
  21. 21.
    Bye A, Muller D, Wilson J, et al: Symptomatic vitamin E deficiency in cystic fibrosis. Arch Dis Child. 1985;60:162–164.PubMedCrossRefGoogle Scholar
  22. 22.
    Kerrebijn KF, Veentjer R, Bonjet VD, et al: The immediate effect of physiotherapy and aerosol treatment on pulmonary function in children with cystic fibrosis. Eur J Respir Dis. 1982;63:35–42.PubMedGoogle Scholar
  23. 23.
    Desmond KJ, Schwenk FW, Thomas E, et al: Immediate and long term effects of chest physiotherapy in patients with cystic fibrosis. J Pediatr. 1983;103:538–542.PubMedCrossRefGoogle Scholar
  24. 24.
    Reisman J, Rivington-Law B, Corey M, et al: Role of conventional physiotherapy in cystic fibrosis. J Pediatr. 1988;113:632–639.PubMedCrossRefGoogle Scholar
  25. 25.
    Stanghelle JK: Physical exercise for patients with cystic fibrosis: A review. Int J Sports Med 1988;9 (suppl):6–18.PubMedCrossRefGoogle Scholar
  26. 26.
    Scanlin TF, in: Fishman AP (ed): Pulmonary Diseases and Disorders, ed 2. New York, McGraw-Hill, 1988, pp 1273–1294.Google Scholar
  27. 27.
    Auerbach HS, Williams M, Kirkpatrick JA, et al: Alternate day prednisone reduccs morbidity and improves pulmonary function in cystic fibrosis. Lancet 1985;2:686–688.PubMedCrossRefGoogle Scholar
  28. 28.
    Brissette S, Zinman R, Reidy M: Disclosure of psychosocial concerns of young adults with a dvanced cystic fibrosis (CF) by a nurse home visiting program. Int J Nurs Stud. 1988;25:67–72.PubMedCrossRefGoogle Scholar
  29. 29.
    Cynamon HA, Milou DE, Valenstein E, et al: Effect of vitamin E deficiency on neurologic function in patients with cystic fibrosis. J Pediatr. 1988;113:636–640.Google Scholar
  30. 30.
    Kollberg H: Cystic fibrosis and physical activity: An introduction. Int J Sports Med. 1988;9(Suppl):2–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Strandvik B: Antibiotic therapy of pulmonary infections in cystic fibrosis: Dosage schedules and duration of treatment. Chest. 1988;95(Suppl 2):146S–149S.Google Scholar
  32. 32.
    Kuzemko JA: Home treatment of pulmonary infections in cystic fibrosis. Chest. 1988;94(Suppl 2):162S–166S.PubMedCrossRefGoogle Scholar
  33. 33.
    Hodson M: Antibiotic treatment: Aerosol therapy. Chest. 1983;94(Suppl 2):156S–160S.CrossRefGoogle Scholar
  34. 34.
    Hiby N.: Hemophilus influenza, Staphylococcus cepaci aureus, Pseudomonas cepacia, and Pseudomonas aeruginosa in patients with cystic fibrosis. Chest. 1988;94(Suppl 2):97S–102S.CrossRefGoogle Scholar
  35. 35.
    Stern RC: The primary care physician and the patient with cystic fibrosis. J Pediatr. 1989;114:31–36.PubMedCrossRefGoogle Scholar
  36. 36.
    Penketh A, Knight RK, Hodson M, et al: Management of pneumothorax in adults with cystic fibrosis. Thorax. 1982;37:850–853.PubMedCrossRefGoogle Scholar
  37. 37.
    Gotz M, Burghuber O, Salzer-Muhar U, et al: Cor pulmonale in cystic fibrosis. JR Soc Med. 1989;82C (Suppl 16):26–31.Google Scholar
  38. 38.
    Durie P, Forstner G: Pathophysiology of the exocrine pancreas in cystic fibrosis. JR Soc Med. 1989;82(Suppl 16):2–10.PubMedGoogle Scholar
  39. 39.
    Huang NN, Schidlow DV, Palmer J, et al: Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis. Am J Med 1987;82:871–879.PubMedCrossRefGoogle Scholar
  40. 40.
    Geddes D, Hodson M: The role of heart and lung transplantation in the treatment of cystic fibrosis. JR Soc Med. 1989;82(Suppl 16):49–53.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Andrew Libertin
  • John S. Heintz

There are no affiliations available

Personalised recommendations